Search

Your search keyword '"Oprean, Cristina"' showing total 45 results

Search Constraints

Start Over You searched for: Author "Oprean, Cristina" Remove constraint Author: "Oprean, Cristina"
45 results on '"Oprean, Cristina"'

Search Results

1. Updated Overall Survival Analysis From IMpower110: Atezolizumab Versus Platinum-Based Chemotherapy in Treatment-Naive Programmed Death-Ligand 1–Selected NSCLC

2. Veliparib with carboplatin and paclitaxel in BRCA-mutated advanced breast cancer (BROCADE3): a randomised, double-blind, placebo-controlled, phase 3 trial

3. Fast Landmark Recognition in Photo Albums

4. Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients

5. Pregnancy in a Young Patient with Metastatic HER2-Positive Breast Cancer—Between Fear of Recurrence and Desire to Procreate

8. Abstract P3-02-05: Interim Analysis Results from a European Disease Registry Study Aimed to Prospectively Observe Treatment Patterns and Outcomes in Patients with HER2+ Unresectable Locally Advanced or Metastatic Breast Cancer

12. Attitudes towards COVID‑19 vaccination in patients with cancer: A cross‑sectional study of 12 oncology centers

13. NEPA, a fixed oral combination of netupitant and palonosetron, improves control of chemotherapy-induced nausea and vomiting (CINV) over multiple cycles of chemotherapy: results of a randomized, double-blind, phase 3 trial versus oral palonosetron

15. Spectrum of BRCA1/2 Mutations in Romanian Breast and Ovarian Cancer Patients

21. Unilateral Orbital Metastasis as the Unique Symptom in the Onset of Breast Cancer in a Postmenopausal Woman: Case Report and Review of the Literature

24. Postmenopausal Breast Cancer in Women, Clinical and Epidemiological Factors Related to the Molecular Subtype: A Retrospective Cohort Study in a Single Institution for 13 Years. Follow-Up Data

25. Endurance of erythrocyte series in chemotherapy

26. Patient-reported outcomes (PROs) in the randomized, phase III IMpower110 study of atezolizumab (atezo) vs chemotherapy in 1L metastatic NSCLC.

29. Efficacy and safety of CetuGEX in recurrent/metastatic squamous cell carcinoma of the head and neck (RM-HNSCC): Results from the randomized phase II RESGEX study.

30. Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients

31. NEPA, a fixed oral combination of netupitant and palonosetron, improves control of chemotherapy-induced nausea and vomiting (CINV) over multiple cycles of chemotherapy: results of a randomized, double-blind, phase 3 trial versus oral palonosetron

32. Randomized Phase II Study of Duligotuzumab (MEHD7945A) vs. Cetuximab in Squamous Cell Carcinoma of the Head and Neck (MEHGAN Study)

33. The UOB-Telecom ParisTech Arabic Handwriting Recognition and Translation Systems for the OpenHart 2013 Competition

34. Reconnaissance de mots manuscrits hors-vocabulaire en utilisant des ressources web

35. Utilisation du Web pour la reconnaissance de mots manuscrits hors vocabulaire

36. Using the World Wide Web for creating dynamic dictionaries in handwritten out-of-vocabulary word recognition

37. Towards user assistance in Data Mining

42. Updated Overall Survival Analysis From IMpower110: Atezolizumab versus Platinum-Based Chemotherapy in Treatment-Naive PD-L1–Selected Non-Small Cell Lung Cancer

44. Determining factors of renal dysfunction during cisplatin chemotherapy.

45. Effectiveness and safety profile of ipilimumab therapy in previously treated patients with unresectable or metastatic melanoma - the Romanian Patient Access Program.

Catalog

Books, media, physical & digital resources